GRI Bio announces 1-for-13 reverse stock split to regain Nasdaq compliance

GRI Bio, Inc.

Reverse split at 1-for-13 effective 4:01 p.m. ET June 17, 2024; split-adjusted trading starts June 18, 2024.
Approximately 6.6M pre-split shares reduce to about 508K post-split shares; no change to authorized shares.
Purpose is to boost per-share price to satisfy Nasdaq minimum bid price requirement for continued listing.
No fractional shares issued; cash in lieu based on June 17 closing price; CUSIP changes to 3622AW 304.
Proportional adjustments made to options, warrants, and convertible securities exercise prices and share counts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.